Author pages are created from data sourced from our academic publisher partnerships and public sources.
A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor.
- Nai-Dong Xing, Sen-tai Ding, +8 authors H. Nishiyama
- Asian journal of andrology
- 7 February 2011
Docetaxel-based combination chemotherapy remains the predominant treatment for castration-resistant prostate cancer. However, taxane-related drug resistance and neurotoxicity have prompted us to… Expand
MicroRNA-375 Suppresses the Tumor Aggressive Phenotypes of Clear Cell Renal Cell Carcinomas through Regulating YWHAZ
Background: MicroRNAs (miRNAs) are key regulators during tumor initiation and progression. MicroRNA-375 (MiR-375) has been proven to play a tumor-suppressive role in various types of human… Expand
The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancers
- Y. Matsui, H. Nishiyama, +6 authors O. Ogawa
- International Journal of Clinical Oncology
- 1 April 2013
BackgroundTo evaluate the survival benefit of gemcitabine and paclitaxel (GT) chemotherapy for patients with metastatic urothelial cancer (UC), a retrospective analysis was performed to compare the… Expand